← All stocks

ENANTA PHARMACEUTICALS INC

ENTA Net selling

CIK 0001177648 #3326 in the set updated 17 Sep 2026

Bought (120 mo)

$256.05K

out of their own pocket, the only kind of buying there is

Sold (120 mo)

$41.80M

$315.52K on a plan · $27.10M straight out of an exercise

Sold at will

$14.38M

45 of 126 sales

Net

−$41.54M

−$14.13M against sales at will

By person

15 insiders · 158 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Adda Nathalie

Sr. VP & Chief Medical Officer

—

$15.32M (43) scheduled

−$15.32M

34,982

0.1201%

$497.79K

+3,831%

Luly Jay R.

President and CEO

$256.05K (1)

$10.08M (17)

−$9.82M

871,871

2.99%

$12.41M

+34.0%

Or Yat Sun

Chief Scientific Officer

—

$5.70M (14) scheduled

−$5.70M

374,854

1.29%

$5.33M

+13.7%

MELLETT PAUL J

Chief Fin. & Admin Officer

—

$4.25M (18)

−$4.25M

95,884

0.3292%

$1.36M

+667.6%

Golumbeski George

Director

—

$2.18M (3) scheduled

−$2.18M

0.0000%

$0.00

—

Ocain Tim

Senior Vice President

—

$2.09M (4) scheduled

−$2.09M

17,547

0.0602%

$249.69K

—

CARTER BRUCE L A

Director

—

$1.26M (7) scheduled

−$1.26M

0.0000%

$0.00

—

Gardiner Nathaniel S.

Chief Legal Officer

—

$334.79K (2)

−$334.79K

108,978

0.3742%

$1.55M

—

Rottinghaus Scott T.

Chief Medical Officer

—

$214.22K (6) scheduled

−$214.22K

23,787

0.0817%

$338.49K

—

Kieffer Tara Lynn

Chief Product Strategy Officer

—

$158.42K (4) scheduled

−$158.42K

33,925

0.1165%

$482.75K

—

Vance Terry

Director

—

$139.49K (1)

−$139.49K

5,800

0.0199%

$82.53K

−62.1%

Luu Brendan

Chief Business Officer

—

$58.70K (3)

−$58.70K

41,634

0.1429%

$592.45K

—

Trout Harry R. III

See Remarks

—

$13.02K (2)

−$13.02K

16,348

0.0561%

$232.63K

+49.8%

Capps Kathleen S.

See Remarks

—

$7.49K (2)

−$7.49K

8,377

0.0288%

$119.20K

+43.7%

Kowalsky Matthew Paul

Chief Legal Officer

—

3,591

0.0123%

$51.10K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

Luly Jay R.

12 Feb 2025

President and CEO

Buy

45,000

$5.69

$256.05K

Show all 158 transactions →

What was left out

Form 4 filings counted 314

Amendments (4/A) skipped 7

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 9

Sales straight out of an exercise 72

Sales at will 45

Transactions with no price 0

Shares from compensation/vesting 1,706,623

Sales filed before the plan box existed 28

History held since 29 Sep 2016